Opthea secures up to US$170m in non-dilutive financing
Filed with ASX · · 4 pages · English
Story so far
Earlier from Opthea
- Opthea Data for OPT-302 for PCV presented at ARVO 2022
- Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting
- S&P DJI Announces March 2022 Quarterly Rebalance
- Opthea Half Year Report and Accounts
- Angiogenesis 2022 -Prof Cheung presentation of PCV data
Later from Opthea
- Opthea Successfully Closes Well Supported US$90m Financing
- Form 6-K with SEC
- Opthea Share Purchase Plan
- Opthea Appendix 4E and Annual Report 2022
- Opthea reports Fiscal Year 2022 Results and Highlights
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea